Cargando…
Redesigning Human 2′-Deoxycytidine Kinase Enantioselectivity for l-Nucleoside Analogues as Reporters in Positron Emission Tomography
[Image: see text] Recent advances in nuclear medicine have allowed for positron emission tomography (PET) to track transgenes in cell-based therapies using PET reporter gene/probe pairs. A promising example for such reporter gene/probe pairs are engineered nucleoside kinases that effectively phospho...
Autores principales: | Muthu, Pravin, Chen, Hannah X., Lutz, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201336/ https://www.ncbi.nlm.nih.gov/pubmed/25079348 http://dx.doi.org/10.1021/cb500463f |
Ejemplares similares
-
Structural basis for activation of the therapeutic l-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase
por: Sabini, Elisabetta, et al.
Publicado: (2007) -
Deletion Mutants of Human Deoxycytidine Kinase mRNA in Cells Resistant to Antitumor Cytosine Nucleosides
por: Obata, Tohru, et al.
Publicado: (2001) -
Targeted Delivery of Deoxycytidine Kinase to Her2-Positive Cells Enhances the Efficacy of the Nucleoside Analog Fludarabine
por: Koduvayur, Sujatha P., et al.
Publicado: (2016) -
A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity
por: Santos, Sean M., et al.
Publicado: (2019) -
Molecular imaging of lymphoid organs and immune activation using positron emission tomography with a new (18)F-labeled 2′-deoxycytidine analog
por: Radu, Caius G., et al.
Publicado: (2008)